Law Enforcement

The State of Ohio Board of Pharmacy is charged with investigating and presenting evidence of violations of any of the federal or state drug laws by any person to the appropriate court (federal, state, or municipal) for prosecution of the offender (O.R.C. Chapter 2925). To assist law enforcement, the Board offers a number of resources that can be accessed from this page.

---

PROSECUTOR NOTIFICATION FORM

In accordance with sections 2929.42, 3719.12, and 3719.121 of the Ohio Revised Code, a prosecutor is required to report certain information regarding the criminal conviction of a licensee or registrant of the State of Ohio Board of Pharmacy. To assist prosecutors in reporting this information, the Board has developed the following reporting form.

• Prosecutor Notification Form

---

OARRS for Law Enforcement Training

The State of Ohio Board of Pharmacy is pleased to announce the release of a new eOPOTA course: OARRS for Law Enforcement. The purpose of this 1-hour course is to provide foundational knowledge on how law enforcement can utilize OARRS to aid them in investigating active drug related cases. Law enforcement officers can access eOPOTA through the Ohio Law Enforcement Gateway (OHLEG).

• Ohio Automated Rx Reporting System Online Training Course for Law Enforcement

---

Naloxone for Law Enforcement

Per Ohio Revised Code Section 2925.61(D) a peace officer employed by a law enforcement agency is not subject to administrative action or criminal prosecution if the peace officer, acting in good faith, obtains naloxone from the peace officer's law enforcement agency and administers the naloxone to an individual who is apparently experiencing an opioid-related overdose.

• Law Enforcement Naloxone Guidance Document
• Law Enforcement Naloxone Transfer Recordkeeping Form
• Naloxone Personally Furnished by Law Enforcement
• Transfer of Naloxone Between Law Enforcement

• Naloxone Resources

---

Controlled Substances Reference Table

The following Controlled Substances Reference Table has been compiled by the State of Ohio Board of Pharmacy to assist law enforcement officials in determining whether or not a drug or drug product is a controlled substance and, if controlled, the schedule in which it has been placed by the Federal Drug Enforcement Administration, the State of Ohio Board of Pharmacy or the Ohio General Assembly.

In addition, the table indicates the number of the finished dosage unit that constitutes bulk amount according to division (D) of section 2925.01 of the Ohio Revised Code.

• Controlled Substance Reference Table - Annual Review Completed for All Drug Entries on 9-15-2023 with Semi-Annual Review Completed 4-1-2024
• Controlled Substance Reference Table - Annual Review Completed for All Drug Entries on 9-15-2023
• Controlled Substance Reference Table - Annual Review Completed for All Drug Entries on 9-15-2022 with Semi-Annual Review Completed 4-1-2023
• Controlled Substance Reference Table - Annual Review Completed for All Drug Entries on 9-15-2022
• Controlled Substance Reference Table - Annual Review Completed for All Drug Entries on 9-15-2021 with Semi-Annual Review Completed 4-1-2022
• Controlled Substance Reference Table - Annual Review Completed for All Drug Entries on 9-15-2021
• Controlled Substance Reference Table - Annual Review Completed for All Drug Entries on 9-15-2020 with Semi-Annual Review Completed 4-1-2021
• Controlled Substance Reference Table - Annual Review Completed for All Drug Entries on 9-15-2020
• Controlled Substance Reference Table - Annual Review Completed for All Drug Entries on 9-15-2019 with Semi-Annual Review Completed 4-1-2020
• Controlled Substance Reference Table - Annual Review Completed for All Drug Entries on 9-15-2019
• Controlled Substance Reference Table - Annual Review Completed for all Drug Entries on 9-15-2018 with Update Completed 4-01-2019
• Controlled Substance Reference Table - Annual Review Completed for All Drug Entries on 9-15-2018
• Controlled Substance Reference Table - Annual Review Completed for All Drug Entries on 9-15-2017 with Update Completed 4-1-2018
• Controlled Substance Reference Table - Annual Review Completed for All Drug Entries on 9-15-2017
• Controlled Substance Reference Table - Annual Review Completed for All Drug Entries on 9-15-2016 with Semi-Annual Update Completed 3-20-2017
• Controlled Substance Reference Table - Annual Review Completed for All Drug Entries on 9-15-2016
• Controlled Substance Reference Table - Annual Review Completed for All Drug Entries on 9-1-2015 with Quarterly Drug Updates Added 4-8-2016
• Controlled Substance Reference Table - Annual Review Completed for All Drug Entries on 9-1-2015 with Quarterly Drug Updates Added 1-19-2016
• Controlled Substance Reference Table - Effective 9.1.2015

---

Ohio Drug Lab Statistics

The National Forensic Laboratory Information System (NFLIS) is a Drug Enforcement Administration (DEA) program that systematically collects drug chemistry analysis results, as well as other related information, from cases analyzed by state, local and federal forensic laboratories. These laboratories analyze substances secured in law enforcement operations across the country. NFLIS offers a valuable resource for monitoring illegal drug abuse and trafficking, including the diversion of legally manufactured pharmaceutical drugs into illegal markets.

To assist law enforcement and public health in monitoring illegal drug abuse and trafficking, the State of Ohio Board of Pharmacy created an online search tool of NFLIS data collected by forensic laboratories in Ohio.

• Ohio Drug Lab Statistics

---

Controlled Substance Scheduling Rules

The State of Ohio Board of Pharmacy has the authority to do any of the following via the Ohio Administrative Code:

1. Add a previously unscheduled compound, mixture, preparation, or substance to any schedule; and
2. Transfer a compound, mixture, preparation, or substance from one schedule to another, provided the transfer does not have the effect under this chapter of providing less stringent control of the compound, mixture, preparation, or substance than is provided under the federal drug abuse control laws.

• 8-Factor Anlaysis - Xylazine
• Governor DeWine Authorizes the State of Ohio Board of Pharmacy to Adopt Emergency Rule to Effectively Ban New Opioids
• U-47700 - Emergency Rule (Effective 5.4.2016)

---

Additional Assistance

If you are a law enforcement agency and need further assistance on a matter relating to the legal distribution of prescription drugs, please call the Board office at 614-466-4143 and ask to speak with the Compliance Department.